Shorepoint Capital Partners LLC Moderna, Inc. Transaction History

Shorepoint Capital Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $6,464 - $9,711	-93 Reduced 1.55%	5,888 $585,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $23,138 - $30,386	-240 Reduced 3.86%	5,981 $617,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $23,700 - $32,106	-200 Reduced 3.11%	6,221 $755,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $79,361 - $115,256	585 Added 10.02%	6,421 $986,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $690,865 - $1.23 Million	5,836 New	5,836 $1.05 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Shorepoint Capital Partners LLC with notifications on news.